Parkside Financial Bank & Trust’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.38K | Hold |
170
| – | – | ﹤0.01% | 2056 |
|
|
2025
Q4 | $1.91K | Buy |
170
+90
| +113% | +$1.03K | ﹤0.01% | 2116 |
|
|
2025
Q3 | $925 | Buy |
80
+40
| +100% | +$468 | ﹤0.01% | 2313 |
|
|
2025
Q2 | $490 | Buy |
40
+29
| +264% | +$365 | ﹤0.01% | 2564 |
|
|
2025
Q1 | $158 | Buy |
+11
| New | +$172 | ﹤0.01% | 2698 |
|
|
2024
Q4 | – | Sell |
-7
| Closed | -$169 | – | 2142 |
|
|
2024
Q3 | $169 | Hold |
7
| – | – | ﹤0.01% | 2038 |
|
|
2024
Q2 | $140 | Sell |
7
-2
| -22% | -$39 | ﹤0.01% | 1988 |
|
|
2024
Q1 | $180 | Hold |
9
| – | – | ﹤0.01% | 1953 |
|
|
2023
Q4 | $202 | Buy |
+9
| New | +$186 | ﹤0.01% | 1943 |
|
|
2023
Q3 | – | Sell |
-93
| Closed | -$2.38K | – | 2052 |
|
|
2023
Q2 | $2.38K | Buy |
+93
| New | +$2.45K | ﹤0.01% | 1635 |
|
|
2022
Q3 | – | Sell |
-15
| Closed | – | – | 1797 |
|
|
2022
Q2 | $0 | Sell |
15
-36
| -71% | -$1.03K | ﹤0.01% | 1814 |
|
|
2022
Q1 | $2K | Sell |
51
-79
| -61% | -$2.54K | ﹤0.01% | 1565 |
|
|
2021
Q4 | $5K | Buy |
130
+29
| +29% | +$938 | ﹤0.01% | 1288 |
|
|
2021
Q3 | $3K | Buy |
101
+50
| +98% | +$1.7K | ﹤0.01% | 1404 |
|
|
2021
Q2 | $2K | Buy |
51
+49
| +2,450% | +$2.03K | ﹤0.01% | 1504 |
|
|
2021
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 1671 |
|
|
2020
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1602 |
|
|
2020
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1517 |
|
|
2020
Q2 | $0 | Sell |
2
-2
| -50% | -$58 | ﹤0.01% | 1486 |
|
|
2020
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1434 |
|
|
2019
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1584 |
|
|
2019
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1565 |
|
|
2019
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1580 |
|
|
2019
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1543 |
|
|
2018
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1453 |
|
|
2018
Q3 | $0 | Buy |
4
+2
| +100% | +$129 | ﹤0.01% | 1524 |
|
|
2018
Q2 | $0 | Sell |
2
-2
| -50% | -$106 | ﹤0.01% | 1530 |
|
|
2018
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1441 |
|
|
2017
Q4 | $0 | Sell |
4
-250
| -98% | -$11.5K | ﹤0.01% | 1365 |
|
|
2017
Q3 | $11K | Hold |
254
| – | – | ﹤0.01% | 695 |
|
|
2017
Q2 | $10K | Hold |
254
| – | – | ﹤0.01% | 730 |
|
|
2017
Q1 | $10K | Hold |
254
| – | – | ﹤0.01% | 699 |
|
|
2016
Q4 | $9K | Hold |
254
| – | – | ﹤0.01% | 721 |
|
|
2016
Q3 | $9K | Hold |
254
| – | – | ﹤0.01% | 734 |
|
|
2016
Q2 | $8K | Hold |
254
| – | – | ﹤0.01% | 728 |
|
|
2016
Q1 | $7K | Hold |
254
| – | – | ﹤0.01% | 718 |
|
|
2015
Q4 | $8K | Hold |
254
| – | – | ﹤0.01% | 699 |
|
|
2015
Q3 | $7K | Buy |
+254
| New | +$8.86K | ﹤0.01% | 711 |
|
Other funds holding AVNS
AC
VCM
VPM
Parkside Financial Bank & Trust's AVNS Position: Q1 2026 in Review
Parkside Financial Bank & Trust held its Avanos Medical (AVNS) position steady in Q1 2026 at 170 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2056.
Parkside Financial Bank & Trust first reported a position in AVNS in Q3 2015 and has held it in 38 quarters since. The position peaked at $11K in Q3 2017. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Parkside Financial Bank & Trust held 170 shares of Avanos Medical worth $2.38K as of Q1 2026.
- Parkside Financial Bank & Trust left its Avanos Medical share count unchanged in Q1 2026.
- Avanos Medical made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2056 holding.
- Parkside Financial Bank & Trust first reported a position in Avanos Medical in Q3 2015 and has held it in 38 quarters since.
- Parkside Financial Bank & Trust's Avanos Medical position peaked at $11K in Q3 2017.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.